Lab Indicators Explained

19 key lab indicators for ADPKD patients — meaning, mechanism, diagnostic value, stage-based patterns, and safety guidance.

⚠ Medical Safety Notice

These explanations are for health education only. A single lab value does not establish a CKD stage or treatment plan. Always interpret results with your nephrologist, considering trends, clinical context, and your individual situation. Do not self-adjust medications based on these values.

🫘 Renal Function Indicators

Estimated Glomerular Filtration Rate (eGFR)

Unit: mL/min/1.73m² Normal: ≥90 normal; 60-89 mildly decreased; 45-59 mild-moderate; 30-44 moderate; 15-29 severe; <15 kidney failure

Purpose: Core indicator for assessing kidney filtration function, CKD staging, and disease progression rate.

Frequency: As recommended by your doctor, typically every 3-6 months.

🔬 Measurement Methods & Standardization

Specimen & Method: Serum or plasma. eGFR is a calculated value from filtration markers and demographic parameters, not a direct measurement.

2021 CKD-EPI eGFRcr: Uses age, sex, and standardized serum creatinine. Limitations: muscle mass, recent cooked meat intake, muscle injury, and acute kidney function changes can affect accuracy.
2021 CKD-EPI eGFRcr-cys: Combined estimation using age, sex, creatinine, and cystatin C. Limitations: cystatin C is also affected by inflammation, thyroid function, and glucocorticoids.

Standardization: Equations require IDMS-traceable creatinine and IFCC-standardized cystatin C. Always compare results from the same laboratory using the same equation.

Pre-test considerations:

Record the equation name reported on the lab report.
Do not use a single eGFR during acute illness, dehydration, or sudden urine output changes to determine long-term stage.
Patients under 18 or 18-25 need age-appropriate equations selected by a physician.

🩺 Clinical Application & Boundaries

Screening: Used with urine albumin-to-creatinine ratio to identify kidney function and injury risk.

Monitoring: Serial trends are more valuable than a single number.

Risk stratification: ADPKD risk classification requires age, imaging, and disease course — eGFR alone is insufficient.

Diagnostic limits: eGFR below 60 for at least 3 months is part of the CKD definition. Structural ADPKD can exist when eGFR is normal.

Emergency significance: Acute decline, oliguria/anuria, or severe symptoms require urgent in-person evaluation.

📊 Interpretation

Target: Maintaining eGFR stability or slowing decline rate is the core treatment goal.

Range	Meaning	Action
≥90	G1: Normal or high filtration	Regular monitoring, watch BP and TKV
60-89	G2: Mildly decreased	Control BP and proteinuria, annual check
45-59	G3a: Mild-moderate decrease	Check every 3-6 months, assess progression
30-44	G3b: Moderate decrease	Check every 3 months, prepare for RRT education
15-29	G4: Severe decrease	Check every 1-3 months, initiate RRT education
<15	G5: Kidney failure	Initiate kidney replacement therapy

Factors: Age (natural decline ~1 mL/min/year), BP control, proteinuria, nephrotoxic drugs, dehydration, contrast media.

💡 Tip: Trends matter more than absolute values. Annual decline rate >5 mL/min suggests rapid progression — discuss RAAP stratification and treatment options with your doctor.

🔗 Related Indicators & Sources

See also: Serum Creatinine (core input for eGFRcr); Cystatin C (complementary estimation); Microalbuminuria (risk combination); Blood Pressure (progression risk).

Related medications: Tolvaptan; ACEI/ARB.

Sources: KDIGO 2024 CKD Guideline; NIDDK eGFR Equations for Adults.

⚠ Limitations: Estimated value, not direct measurement. Affected by age, muscle mass, and diet. May be normal in early ADPKD.

Serum Creatinine (SCr)

Unit: μmol/L Normal: Male 53-106; Female 44-97 (varies by laboratory)

Purpose: Traditional kidney function indicator, used to calculate eGFR.

Frequency: As recommended, typically with eGFR.

🔬 Measurement Methods & Standardization

Specimen: Serum or plasma. The assay method and laboratory affect result comparability.

Jaffe method: Creatinine reacts with picric acid for colorimetric measurement. Widely used. Limitations: non-creatinine chromogens can interfere, especially at low creatinine levels.
Enzymatic method: Uses enzymatic reactions to measure creatinine. Generally higher specificity. Limitations: different platforms and calibration can still cause differences.
IDMS-traceable calibration: Aligns routine results with international reference measurement systems — the foundation for eGFR equation use. Limitations: cannot eliminate physiological variability from muscle mass, diet, or acute illness.

Standardization: When comparing trends, prefer the same laboratory and method. Record the unit (μmol/L or mg/dL).

Pre-test considerations:

Recent strenuous exercise or large amounts of cooked meat can transiently alter results.
Fever, vomiting, diarrhea, oliguria, urinary obstruction, and new medications should be recorded.
Do not substitute a single result for physician assessment.

🩺 Clinical Application & Boundaries

Screening: Primary input for eGFR calculation.

Monitoring: Interpret with baseline, eGFR, and cystatin C trends.

Risk stratification: A single creatinine value cannot compare risk between patients of different body size, age, or sex.

Diagnostic limits: Creatinine elevation can reflect decreased clearance, increased generation, altered secretion, volume changes, or assay interference.

Emergency significance: Short-term significant elevation, oliguria/anuria, difficulty breathing, repeated vomiting, high fever with flank pain, or gross hematuria all require urgent in-person evaluation.

📊 Interpretation

Target: Stable or slowly rising creatinine suggests stable kidney function. Acute elevation requires attention.

Range	Meaning	Action
Within normal range	Kidney function relatively stable	Regular monitoring
Mild elevation (1-1.5× upper limit)	Needs attention, interpret with eGFR	Recheck and discuss with doctor
Moderate elevation (1.5-2× upper limit)	Significant kidney function decline	See doctor promptly
Acute rise (>25% short-term)	Possible acute kidney injury	Seek immediate medical care — check for dehydration, drugs, obstruction

Factors: Muscle mass (higher in athletes), age (lower in elderly), sex, diet (large meat intake can transiently raise), dehydration, nephrotoxic drugs (NSAIDs, contrast).

💡 Tip: Always interpret creatinine with eGFR. Results from the same laboratory are more comparable. Do not attempt to "lower creatinine" yourself — acute rise needs medical evaluation.

🔗 Related Indicators & Sources

See also: eGFR (estimation relationship); Cystatin C (complementary check); BUN (joint assessment); Electrolytes (complication assessment).

Related medications: ACEI/ARB; Tolvaptan.

Sources: KDIGO 2024 CKD Guideline; KDIGO AKI Guideline.

⚠ Limitations: Affected by muscle mass, age, and sex. Less accurate than eGFR when used alone.

Cystatin C (CysC)

Unit: mg/L Normal: 0.5-1.0 mg/L (varies by laboratory)

Purpose: Alternative filtration marker less affected by muscle mass, used for combined eGFR estimation.

Frequency: When creatinine-based eGFR may be inaccurate or near a treatment decision threshold.

⚠ Limitations: Affected by inflammation, thyroid dysfunction, and glucocorticoids. Not a direct GFR measurement.

Blood Urea Nitrogen (BUN)

Unit: mmol/L Normal: 2.9-7.5 mmol/L (varies by laboratory)

Purpose: Assesses kidney excretion function alongside creatinine. Affected by protein intake, dehydration, and GI bleeding.

Frequency: Typically with creatinine.

⚠ Limitations: Highly affected by non-renal factors (diet, hydration, bleeding). Less specific than creatinine for kidney function.

🧪 Urine Indicators

Urine Protein-to-Creatinine Ratio (UPCR)

Unit: mg/g Normal: <150 mg/g

Purpose: Estimates 24-hour protein excretion from a spot urine sample.

Frequency: Every 3-6 months or as recommended.

⚠ Limitations: Affected by exercise, fever, and posture. A single elevated value should be confirmed.

Microalbuminuria (UACR)

Unit: mg/g Normal: <30 mg/g; 30-300 microalbuminuria; >300 macroalbuminuria

Purpose: Early marker of kidney damage, detects albumin-specific proteinuria before UPCR becomes abnormal.

Frequency: Annually or as recommended.

⚠ Limitations: Can be transiently elevated by exercise, fever, UTI, or heart failure.

🩸 Blood Indicators

Hemoglobin (Hb)

Unit: g/L Normal: Male ≥130; Female ≥115 (CKD-specific thresholds)

Purpose: Screens for CKD-related anemia (renal anemia due to EPO deficiency).

Frequency: Annually in early CKD, more frequently in advanced stages.

⚠ Limitations: Must be interpreted with iron studies. Other causes of anemia must be excluded.

Iron Metabolism (Ferritin, TSAT)

Unit: Ferritin μg/L; TSAT % Target (CKD): Ferritin >100, TSAT >20% (varies by guideline)

Purpose: Assesses iron stores and availability before and during ESA therapy.

Frequency: With hemoglobin monitoring in CKD.

⚠ Limitations: Ferritin is an acute-phase reactant — elevated in inflammation without iron overload.

💓 Blood Pressure Indicator

Blood Pressure (BP)

Unit: mmHg Target: <130/80 mmHg (per KDIGO; individualized)

Purpose: Hypertension is common and early in ADPKD. BP control is critical for slowing progression and reducing cardiovascular risk.

Frequency: Home monitoring regularly; clinic at every visit.

⚠ Limitations: Single readings are insufficient. Use validated monitors and proper technique. White-coat and masked hypertension are common.

⚡ Metabolic Indicators

Uric Acid (UA)

Unit: μmol/L Normal: Male ≤420; Female ≤360 (varies)

Purpose: Hyperuricemia is common in ADPKD and can be worsened by tolvaptan. Monitor for gout risk.

Frequency: With renal function panels, especially during tolvaptan therapy.

⚠ Limitations: Elevated uric acid does not always require treatment — decision is clinical.

Lipid Panel (LDL-C, TC, TG)

Unit: mmol/L Target: LDL-C per cardiovascular risk (typically <2.6 in CKD)

Purpose: Assesses cardiovascular risk. CKD patients have elevated cardiovascular risk.

Frequency: Annually or as recommended.

⚠ Limitations: Interpret with overall cardiovascular risk, not in isolation.

🦴 Bone Mineral Metabolism Indicators

Parathyroid Hormone (PTH)

Unit: pg/mL Target (CKD G3-G5): ~2-9× upper normal limit (per KDIGO)

Purpose: Diagnoses and monitors CKD-MBD (chronic kidney disease-mineral and bone disorder).

Frequency: Every 3-6 months in CKD G3b-G5.

⚠ Limitations: Must be interpreted with calcium, phosphate, and vitamin D levels.

Electrolytes (K+, Na+, Ca²+, PO₄³-)

Unit: mmol/L K+: 3.5-5.0; Na+: 135-145; Ca²+: 2.1-2.6; PO₄³-: 0.8-1.5 (varies)

Purpose: Monitors for hyperkalemia, hyponatremia, and CKD-MBD abnormalities. Critical for medication safety (ACEI/ARB, diuretics, tolvaptan).

Frequency: With renal function panels, more frequently with medication changes.

⚠ Limitations: Potassium can be falsely elevated (hemolysis) — confirm critical values.

🫀 Liver Function Indicators

Liver Function (ALT, AST, Bilirubin)

Unit: U/L (ALT/AST); μmol/L (Bilirubin) Varies by laboratory

Purpose: Essential for tolvaptan safety monitoring (hepatotoxicity risk). Also relevant for polycystic liver disease assessment.

Frequency: As per tolvaptan monitoring protocol (typically monthly initially, then quarterly).

⚠ Limitations: Mild ALT elevation can occur with many medications. Pattern and magnitude matter more than single values.

🩹 Coagulation Indicators

Coagulation (PT/INR, APTT)

Unit: seconds / INR INR target varies by indication (e.g., 2.0-3.0 for atrial fibrillation)

Purpose: Monitors anticoagulation status in CKD patients (increased bleeding risk with declining kidney function). Relevant for dialysis preparation.

Frequency: Per anticoagulation protocol.

⚠ Limitations: INR can be affected by liver function, diet (vitamin K), and drug interactions.

🔥 Inflammation Indicators

C-Reactive Protein (CRP)

Unit: mg/L Normal: <10 mg/L (conventional); <3 mg/L (high-sensitivity)

Purpose: Marker of infection and inflammation. Important for distinguishing cyst infection from other causes of flank pain.

Frequency: When infection or inflammation is suspected.

⚠ Limitations: Non-specific — elevated in many conditions. Must be interpreted clinically.

📸 Imaging Indicators

Total Kidney Volume (TKV)

Unit: mL (bilateral sum) Normal: ~200-300 mL (varies by age, sex, height)

Purpose: Key indicator for assessing cyst burden and disease progression rate. Core parameter for Mayo Imaging Classification and RAAP risk stratification.

Frequency: Typically annually for risk stratification.

⚠ Limitations: TKV alone does not equal risk classification. Mayo Imaging Classification requires age, height, imaging method, and total kidney volume. Absolute volume without context should not be used to imply formal risk category — consult your physician for proper classification.

References

KDIGO 2025 Clinical Practice Guideline on ADPKD — KDIGO. View guideline
KDIGO 2024 CKD Guideline — KDIGO. View PDF
NIDDK eGFR Equations for Adults — NIDDK. View page
KDIGO AKI Guideline (2012) — KDIGO. View PDF

🐛 Found an error in this page? Tell us

Evidence level: A–B (per KDIGO standard)
Limitations: Individual circumstances vary — always consult your nephrologist.

← Back to Knowledge Base